Jefferies Group LLC Spring Works Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	SELL	$24.1 - $39.66 $36,150 - $59,489	-1,500 Reduced 6.25%	22,500 $641,000
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $542,250 - $892,349	22,500 New	22,500 $642,000
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $440,640 - $1.44 Million	-24,000 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$48.97 - $65.46 $73,455 - $98,189	1,500 Added 6.67%	24,000 $1.35 Million
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $1.18 Million - $1.57 Million	24,000 New	24,000 $1.36 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.34B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.